Prime Medicine Inc (PRME)
7.04
+0.28
(+4.14%)
USD |
NASDAQ |
May 16, 16:00
7.02
-0.02
(-0.28%)
After-Hours: 20:00
Prime Medicine Shareholders Equity (Quarterly): 243.77M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 243.77M |
| December 31, 2023 | 133.07M |
| September 30, 2023 | 193.96M |
| June 30, 2023 | 240.10M |
| March 31, 2023 | 278.80M |
| Date | Value |
|---|---|
| December 31, 2022 | 316.27M |
| September 30, 2022 | 172.70M |
| June 30, 2022 | 200.74M |
| December 31, 2021 | 239.56M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
133.07M
Minimum
Dec 2023
316.27M
Maximum
Dec 2022
224.33M
Average
239.56M
Median
Dec 2021
Shareholders Equity (Quarterly) Benchmarks
| 10x Genomics Inc | 718.83M |
| Verve Therapeutics Inc | 583.07M |
| Ionis Pharmaceuticals Inc | 296.52M |
| Solid Biosciences Inc | 126.48M |
| Beam Therapeutics Inc | 913.49M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 311.38M |
| Total Liabilities (Quarterly) | 67.62M |
| Current Ratio | 8.905 |